# Arbutus Biopharma Corp: Form 8-K, filed May 26, 2022

- Company: [Arbutus Biopharma Corp](/companies/abus.md) (CIK 1447028)
- Form: 8-K
- Filed: 2022-05-26
- Accepted by EDGAR: May 26, 2022, 17:06 ET
- Period: 2022-05-26
- Accession: 0001171843-22-003988
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1447028/000117184322003988/f8k_052522.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1447028/000117184322003988/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1447028/000117184322003988/f8k_052522.htm

Filed May 26, 2022.
Source: SEC EDGAR, the filing index for accession 0001171843-22-003988. Last ingested by Listed: Nov 10, 2026, 16:58 ET. No prices; not investment advice.